External regulatory, economic, and technological forces ensured that the story of 2025 for CDMO marketers was turbulence. How will marketing teams adapt in 2026? 

149 marketing leaders shared their predictions and strategies in the 2026 CDMO Marketing Trends Report from Altitude Marketing. Join John Boogaard, the Senior Director of Global Marketing at Adhesives Research, Inc. and ARx Pharma., and Adam Smartschan, the Chief Strategy Officer at Altitude Marketing, in a webinar that explores the results in the report as well as their insight into both the internal strategies and industry headwinds that will shape CDMO marketing through the next year. 

You’ll learn:  

• Which channels generate the most qualified leads 
• How budgets and team structures are evolving 
• Where AI is delivering real efficiency gains 
• How external pressures are impacting marketing performance 

Register now for a data-driven look at the trends shaping CDMO marketing in 2026. 

The webinar will provide updates from the U.S. Pharmacopeia (USP) efforts to develop and implement standardized System Suitability Standards (SSS) for Extractables and Leachables (E&L) testing, addressing the lack of global regulatory guidance and variability in data quality. Initiated in 2021, the project involved extensive stakeholder engagement, laboratory studies, and a global round-robin study across 13 labs using GC-MS and LC-MS platforms. The standards aim to ensure instrument performance and data reliability through carefully designed compound mixtures. Based on feedback and study results, the mixtures were re-optimized and stability-tested, with plans for industry release in Q3 2026 and potential inclusion in USP General Chapter <1663>. The presentation also highlights ongoing efforts to develop standards for rubber oligomers and materials of construction (MOC), and updates to enhance the USP leachables General Chapter <1664> for various dosage forms, reinforcing USP’s commitment to enhancing patient safety and regulatory harmonization.

Join Samsung Biologics to explore how ExellenS™ delivers standardized equivalency and accelerated speed across our global manufacturing network. Leveraging integrated manufacturing control systems (MCS) and ≥95% standardized facility design, we achieve seamless scalability and reduced tech transfer timelines. With 100% on-time delivery maintained despite global disruptions, our unified platforms empower predictable outcomes for complex supply chains.